Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

244
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
244
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

192
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
192
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.4K
Hepatic Portal System01:21

Hepatic Portal System

1.2K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
1.2K
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

118.1K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
118.1K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

57
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
57

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Rifaximin ameliorates cirrhotic portal hypertension through suppression of microbiome-derived deoxycholic acid.

Journal of hepatology·2026
Same author

SOX9 promotes hepatocyte proliferation via upregulating TGF-α expression during liver regeneration.

Hepatology international·2025
Same author

Endothelial Tgfbr2 Deficiency Ameliorate Liver Fibrosis Through Regulating Angiocrine Signalling and Macrophage Accumulation.

Liver international : official journal of the International Association for the Study of the Liver·2025
Same author

The α-1 Adrenergic Receptor Antagonist Doxazosin Attenuates Liver Fibrosis by Alleviating Sinusoidal Capillarization and Liver Angiogenesis.

Advanced biology·2024
Same author

Sulodexide attenuates liver fibrosis in mice by restoration of differentiated liver sinusoidal endothelial cell.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2023
Same author

Novel therapeutics for portal hypertension and fibrosis in chronic liver disease.

Pharmacology & therapeutics·2020
Same journal

A Kidney Transplant Recipient with Severe Chronic Diarrhea and Villous Atrophy.

Gastroenterology·2026
Same journal

A Clinical Perspective on Comparative Models of Pancreatic Cyst Surveillance.

Gastroenterology·2026
Same journal

Reply to Jiang et al.

Gastroenterology·2026
Same journal

An Unusual Cause of Chronic Hematochezia.

Gastroenterology·2026
Same journal

How important is fiber in the Crohn's disease story?

Gastroenterology·2026
Same journal

Reply to "Critical Appraisal of the Integrin αV-YAP-CTGF Axis in Congestive Hepatopathy".

Gastroenterology·2026
查看所有相关文章

相关实验视频

Updated: Jun 23, 2025

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
09:37

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Published on: August 1, 2018

15.0K

在门静脉中准5-基三胺受体1A,以降低门脉高血压.

Chang-Peng Zhu1, Shu-Qing Liu1, Ke-Qi Wang1

  • 1Department of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China.

Gastroenterology
|June 21, 2024
PubMed
概括
此摘要是机器生成的。

这项研究表明,血清素 (5-HT) 通过通过5-HT受体1A (HTR1A) 收缩门静脉 (PV) 来增加门高血压 (PH). 用阿尔维林等抗体向HTR1A可能可以治疗PH.

关键词:
5 - - 氧三胺胺是一种5 - - 氧三胺.阿尔维林 (Alverine) 是一个名字.这就是HTR1A.门户高血压的高血压.门静脉 顺滑肌细胞 肌肉细胞

更多相关视频

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

20.3K
Isolating and Using Sections of Bovine Mesenteric Artery and Vein as a Bioassay to Test for Vasoactivity in the Small Intestine
07:32

Isolating and Using Sections of Bovine Mesenteric Artery and Vein as a Bioassay to Test for Vasoactivity in the Small Intestine

Published on: October 7, 2014

9.7K

相关实验视频

Last Updated: Jun 23, 2025

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
09:37

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Published on: August 1, 2018

15.0K
Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

20.3K
Isolating and Using Sections of Bovine Mesenteric Artery and Vein as a Bioassay to Test for Vasoactivity in the Small Intestine
07:32

Isolating and Using Sections of Bovine Mesenteric Artery and Vein as a Bioassay to Test for Vasoactivity in the Small Intestine

Published on: October 7, 2014

9.7K

科学领域:

  • 肝病学 肝病学是一种肝病学.
  • 血管生物学 血管生物学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 门性高血压 (PH) 是慢性肝病的常见并发症.
  • 在肝硬化患者中观察到周围5-基三胺 (5-HT) 水平升高.
  • 门静脉 (PV) 中的5-HT受体1A (HTR1A) 在PH病原发生中的作用尚不清楚.

研究的目的:

  • 在PH的背景下,研究HTR1A在PV中的功能和机制.
  • 探索HTR1A作为PH的潜在治疗点.

主要方法:

  • 通过注射硫乙胺,胆道绑定或部分PV绑定建立了PH模型.
  • 使用RT-PCR,现场杂交和免疫光分析了HTR1A的表达.
  • 评估了5-HT,HTR1A激动剂 (8-OH-DPAT) 和对抗剂 (WAY-100635) 对门口压力 (PP) 的影响,通过在位宫内输液进行了评估.
  • 使用Htr1a-knockout和VSMC特定的Htr1a-knockout模型来证实HTR1A在调节PP中的作用.

主要成果:

  • 在PH模型和肝硬化患者的PV中,HTR1A表达显著上调.
  • 5-HT和8-OH-DPAT增加了PP并诱导了孤立的PV收缩,而WAY-100635降低了PP.
  • 对Htr1a的遗传删除阻止了PH的发展.
  • 5-HT诱导的光伏平滑肌细胞收缩是由通过HTR1A通过cAMP途径调解的.
  • 阿尔维林是一种HTR1A抗剂,在各种PH模型中降低了PP.

结论:

  • 5-HT通过HTR1A诱导PV收缩而加剧PH.
  • HTR1A被确定为PH的有前途的治疗标.
  • 阿尔维林显示出作为治疗PH的临床候选人的潜力.